Table 3 Results of single-factor analysis
From: Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma
Influencing factor | Number | 5-year OS (%) | P | 5-year PFS (%) | P | 5-year LC (%) | P | 5-year FFDM (%) | P |
|---|---|---|---|---|---|---|---|---|---|
Totality | 89 | 80.2 | 60.5 | 78.8 | 80.8 | ||||
Age | 0.302 | 0.501 | 0.979 | 0.685 | |||||
<25 years old | 30 | 86.1 | 66.5 | 79.7 | 83.2 | ||||
≥25 years old | 59 | 77.1 | 57.5 | 78.4 | 79.5 | ||||
Tumor size | 0.048 | 0.606 | 59.2 | 0.053 | |||||
≤5 cm | 35 | 91.4 | 65.7 | 76.8 | 91.4 | ||||
>5 cm | 54 | 73.1 | 57.2 | 80.0 | 73.9 | ||||
Chemotherapy method | 0.015 | 0.313 | 0.883 | 0.028 | |||||
Adjuvant chemotherapy | 9 | 55.6 | 44.4 | 71.1 | 55.6 | ||||
Neoadjuvant chemotherapy | 75 | 84.5 | 63.8 | 79.3 | 83.8 | ||||
Chemotherapy course | 0.287 | 0.726 | 0.958 | 0.403 | |||||
<6 | 39 | 76.8 | 59.0 | 78.7 | 76.9 | ||||
≥6 | 45 | 85.2 | 64.0 | 79.0 | 84.1 |